From: Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid
Clinical characteristics | Number (Percentile) |
---|---|
Age (Mean/Median, y) | 49.1 ± 13.7/49.0 (20–78) |
Time of follow-up (Mean/Median, y) | 5.5/3.0 (0.08–32) |
Tumor size (N = 116) | 10.0 ± 5.1 (1.0- 26.0) |
Coexisted Carcinoid syndrome | 1 (0.84%) |
Functional struma | 22 (18.5%) |
Extra-ovarian metastasis | |
Yes | 4 (3.4%) |
No | 115 (96.6%) |
Lymph node resection positive (N = 7) | 0 (0%) |
Metastatic site | |
Liver | 2 |
Bowel | 2 |
Peritoneum | 1 |
Omentum | 1 |
Appendix | 1 |
Recurrence | 3 (2.6%) |
Liver | 1 |
Multiple bone and breast | 1 |
Contralateral ovary and para-aortic lymph nodes | 1 |
Treatment in recurrence | |
No | 1 |
RSO + para-aortic lymph node resection | 1 |
Radiotherapy + chemotherapy | 1 |